Opposing actions of native and oxidized lipoprotein on motor neuron- like cells

Experimental Neurology

Volumn 157, Issue 1, 1999, Pages 202-210

  Keller, Jeffrey N ^a   Hanni, Keith B ^a   Pedersen, Ward A ^a   Cashman, Neil R ^c   Mattson, Mark P ^a   Gabbita, S Prasad ^a   Friebe, Veronica ^a   Markesbery, William R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Calcium; Caspase; Low density lipoprotein; Oxidized low density lipoprotein; Reactive oxygen species

Indexed keywords

CASPASE; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVATION; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MACROMOLECULE; MOTONEURON; MOUSE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EID: 0032942399     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7043     Document Type: Article

References (61)

1. Bassa B. V., Roh D. D., Kirshenbaum M. A., Kamanna V. S. Atherogenic lipoproteins stimulate mesangial cell p42 mitogen activated protein kinase. J. Am. Soc. Nephrol. 9:1998;488-496.
2. Beal M. F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1996;357-366.
3. Beal M. F., Ferrante R. J., Browne S. E., Matthews R. T., Kowall N. W., Brown R. H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:1997;646-654.
4. Beckman J. S., Crow J. P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21:1993;330-334.
5. Bredesen D. E. Neuronal apoptosis. Ann. Neurol. 38:1995;839-851.
6. Cashman N. R., Durham H. D., Blusztajin J. K., Oda K., Tabira T., Shaw I. T., Dahrouge S., Antel J. P. Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dynamics. 194:1992;209-221.
7. Choi, D. W. Calcium and excitotoxic neuronal injury, Ann. N.Y. Acad. Sci. 747, 162, 171.
8. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
9. Czubryt M. P., Panagia V., Pierce G. N. The roles of free radicals, peroxides and oxidized lipoproteins in second messenger system dysfunction. Myocardial Ischemia: Mechanisms, Reperfusion, Protection. 1996;Birkhauser Verlag.
10. Dehouc B., Fenart L., Dehouc M. P., Pierce A., Torpier G., Cecchelli R. A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier. J. Cell Biol. 138:1997;877-889.
11. Dimmeler S., Haendeler J., Galle J., Zeiher A. M. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the response to injury, hypothesis. Circulation. 95:1997;1760-1763.
12. D'Mello S. R. Molecular regulation of neuronal apoptosis. Curr. Top. Dev. Biol. 39:1998;187-213.
13. Draczynska-Lusiak B., Doung A., Sun A. Y. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer's disease. Mol. Chem. Neuropathol. 33:1998;139-148.
14. Esterbauer H., Zollner H., Lang J. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11:1991;81-128.
15. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 13:1992;341-390.
16. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57:1993;779S-786S.
17. Faulkner K. M., Liochev S. I., Fridovich I. Stable Mn(III) porphyrins mimic superoxide dismutasein vitroin vivo. J. Biol. Chem. 269:1994;23471-23476.
18. Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., Kowall N. W., Brown R. H., Beal M. F. Evidence for increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69:1998;2064-2207.
19. Furukawa K., Estus S., Fu W., Mark R. J., Mattson M. P. Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways. J. Cell Biol. 136:1997;1137-1149.
20. Goto K., Ishige A., Sekiguchi K., Iizuka S., Sugimoto A., Yuzurihara M., Aburada M., Hosoya E., Kogure K. Effects of cyclohexamide on delayed neuronal death in rat hippocampus. Brain Res. 534:1990;299-302.
21. Gotz M. E., Kunig G. A., Riederer P., Youdim M. B. H. Oxidative stress: Free radical production in neural degeneration. Pharmacol. Ther. 63:1994;37-122.
22. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
23. Harada-Shiba M., Kinoshita M., Kamido H., Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J. Biol. Chem. 273:1998;9681-9687.
24. Heinecke J. W. Free radical modification of low-density lipoprotein: Mechanisms and biological consequences. Free Radic. Biol. Med. 3:1987;65-73.
25. Horakova L., Stolc S. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen. Pharmacol. 30:1998;627-638.
26. Kalaria R. N. Cerebral vessels in aging and Alzheimer's disease. Pharmacol. Ther. 72:1996;193-214.
27. Keller J. N., Kindy M. S., Holtsberg F. W., St. Clair D. K., Yen H. C., Germeyer A., Bruce-Keller A. J., Hutchins J. B., Steiner S. M., Mattson M. P. Mitochondrial MnSOD prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
28. Keller J. N., Mattson M. P. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in nervous system. Rev. Neurosci. 9:1998;105-116.
29. Kopprasch S., Leonhardt W., Pietzsch J., Kuhne H. Hypochlorite-modified low density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells. Atherosclerosis. 136:1998;315-324.
30. Kruman I. A., Bruce-Keller A. J., Bredesen D. E., Waeg G., Mattson M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
31. Kruman I. A., Guo Q., Mattson M. P. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51:1998;293-308.
32. Lenz M. L., Hughes H., Mitchell J. R., Via D. P., Guyton J. R., Taylor A. A., Gotto A. M., Smith C. V. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J. Lipid Res. 31:1990;1043-1050.
33. Leppala J., Kallio M., Nikula T., Nikkinen P., Liewandahl K., Jaaskelainen J., Savolainen S., Gylling H., Hiltunen J., Callaway J. Accumulation of 99mTc-low density lipoprotein in human malignant glioma. Br. J. Cancer. 71:1995;383-387.
34. Lucarelli M., Gennarelli M., Cardelli P., Novelli G., Scarpa S., Dallapiccola B., Strom R. Expression of receptors for native and chemically modified LDL in brain microvessels. FEBS Lett. 401:1997;53-58.
35. Luoma J. S., Stralin P., Marklund S. L., Hiltunen T. P., Yla-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 18:1998;157-167.
36. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., Mattson M. P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
37. Mato M., Oolkawara S., Sakamoto A., Aikawa E., Ogawa T., Mitushashi U., Masuzawa T., Suzuki H., Honda M., Yazaki Y., Watanabe E., Luoma J., Yla-Herttuala S., Fraser I., Gordon S., Kodama T. Involvement of specific macrophage-lineage cells surrounding arterioles in barrier and scavenger function in brain cortex. Proc. Natl. Acad. Sci. USA. 93:1996;3269-3274.
38. Mattson M. P., Zhang Y., Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121:1993;1-13.
39. Mattson M. P., Barger S. W., Begley J. G., Mark R. J. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-215.
40. Mattson M. P., Furukawa K. Programmed cell life. Rev. Neurol. Neurosci. 9:1996;191-205.
41. McConkey D. J., Orrenius S. The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun. 239:1997;357-366.
42. Mooradian A. D. Potential mechanisms of the age-related changes in the blood-brain barrier. Neurobiol. Aging. 15:1994;751-755.
43. Newcombe, J. H. Li, M. L. Cuzner, Low density lipoprotein uptake by macrophages in MS plaques: Implications for pathogenesis, Neuropathol. Appl. Neurobiol. 20, 152, 162.
44. Nishio E., Arimura S., Watanabe T. Oxidized LDL induces apoptosis in cultured smooth muscle cells: A possible role for 7-ketocholesterol. Biochem. Biophys. Res. Commun. 223:1996;413-418.
45. Patel R. P., Diczfalusy U., Dzeletovic S., Wilson M. T., Darley-Usmar V. M. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J. Lipid Res. 37:1996;2361-2371.
46. Pedersen W. A., Cashman N. R., Mattson M. P. The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells. Exp. Neurol. 1998.
47. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S., Smith R. G., Kasarskis E., Mattson M. P. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44:1998;819-824.
48. Ratan R. R., Murphy T. H., Baraban J. M. Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J. Neurosci. 14:1994;4385-4392.
49. Resink T. J., Bochkov V. N., Hahn A. W. A., Philippova M. P., Buhler F. R., Tkachuk V. A. Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive, and synergistic effects. J. Vasc. Res. 32:1995;328-338.
50. 2. Biochem. J. 330:1998;1309-1315.
51. Schumacher M., Eber B., Tatzber F., Kaufman P., Halwachs G., Fruhwald F. M., Zweiker R., Esterbauer H., Klein W. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction. Free Radic. Biol. Med. 18:1995;1087-1091.
52. Serghini R., Froissard P., Sola B., Duval D. Cyclohexamide and actinomycin D block the toxic effect of glutamic acid on PC12 cells. Neuroreport. 6:1994;29-32.
53. Springer J. E., Azbill R. D., Mark R. J., Begley J. G., Waeg G., Mattson M. P. 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68:1997;2469-2476.
54. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963-20966.
55. Stewart P. A., Hayakawa K., Akers M. A., Vinters H. V. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab. Invest. 67:1992;734-742.
56. Stulnig T. M., Jurgens G., Chen Q., Moll D., Schonitzer D., Jarosch E., Wick G. Properties of low density lipoprotein relevant to oxidative modifications change paradoxically during aging. Atherosclerosis. 126:1996;85-94.
57. Sugawa M., Ikeda S., Kushima Y., Takashima Y., Cynshi O. Oxidized low density lipoprotein caused CNS neuron cell death. Brain Res. 761:1997;165-172.
58. Szabo C., Day B. J., Salzman A. L. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett. 381:1996;82-86.
59. Waeg G., Dimsity G., Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic. Res. 25:1996;149-159.
60. Zhu Y., Lin J. H., Liao H. L., Friedli O., Verna L., Marten N. W., Straus D. S., Stemerman M. B. LDL induces transcription factor activator protein-1 in human endothelial Cells. Atherioscler. Thromb. Vasc. Biol. 18:1998;473-480.
61. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.